首页> 中国专利> 一种SYBR Green衍生物及其在细胞线粒体DNA荧光成像中的应用

一种SYBR Green衍生物及其在细胞线粒体DNA荧光成像中的应用

页面导航

摘要
著录项
法律信息
相似文献

摘要

一种SYBR Green衍生物及其在细胞线粒体DNA荧光成像中的应用，涉及细胞生物学领域，所述SYBR Green衍生物是通过对SYBR Green原料烷基化修饰得到的季铵盐产物；所述SYBR Green衍生物的修饰剂包括亲电试剂或连接有亲电取代基的功能分子。所述SYBR Green衍生物作为荧光探针在细胞线粒体DNA荧光成像中的应用，该类探针能够准确定位于活细胞的线粒体DNA中进行实时成像并反映线粒体的电势。

著录项

公开/公告号CN110672572A

专利类型发明专利
公开/公告日2020-01-10

原文格式PDF
申请/专利权人厦门大学;
展开▼

申请/专利号CN201910987600.4
发明设计人韩守法;邹小雪;施一龙;
展开▼

申请日2019-10-17
分类号
代理机构厦门南强之路专利事务所(普通合伙);
代理人张素斌
地址 361005 福建省厦门市思明南路422号
入库时间 2023-12-17 06:17:37

法律信息

法律状态公告日

法律状态信息

法律状态
2020-07-31

授权

授权
2020-02-11

实质审查的生效 IPC(主分类):G01N21/64 申请日:20191017

实质审查的生效
2020-01-10

公开

公开

相似文献

专利
中文文献
外文文献

1. 一种SYBR Green衍生物及其在细胞线粒体DNA荧光成像中的应用 [P] . 中国专利： CN110672572B . 2020.07.31
2. 一种SYBR Green衍生物及其在细胞线粒体DNA荧光成像中的应用 [P] . 中国专利： CN110672572A . 2020-01-10
3. Method of inhibiting the occurrence of one or more of the following conditions: monocyte / macrophage proliferation; or the proliferation of smooth muscle cells; or the expression of cd36 receptors; or the absorption of low-density lipoprotein - oxidized ldl, method of relief of symptoms of treatment or prevention of atherosclerosis; diabetes; alzheimer's disease, method of inhibiting the occurrence of plaque formation in the vascular system, method of relieving inflammation associated with the occurrence of one or more of the following conditions: the proliferation of monocytes, the proliferation of smooth muscle cells, the expression oxidized ldl or decontaminating receptor, pharmaceutical composition, use of an effective amount of one or more derivatives or phosphate of one or more electron transfer agents together with a suitable vehicle or diluent, use of an effective amount of one or more (alpha) -tocopherol phosphate derivatives together with an appropriate vehicle or diluent an [P] . BRPI0406484A . 2005-12-06

机译：抑制下列一种或多种状况发生的方法：单核细胞/巨噬细胞增殖;或平滑肌细胞的增殖;或cd36受体的表达;或低密度脂蛋白-氧化低密度脂蛋白的吸收，缓解或治疗动脉粥样硬化症状的方法;糖尿病;阿尔茨海默氏病，抑制血管系统中斑块形成的方法，缓解与以下一种或多种状况有关的炎症的方法：单核细胞的增殖，平滑肌细胞的增殖，氧化的ldl或去污受体，药物组合物，有效量的一种或多种衍生物或一种或多种电子转移剂的磷酸盐与合适的媒介物或稀释剂一起使用，有效量的一种或多种α-生育酚磷酸酯衍生物一起使用用适当的媒介物或稀释剂
4. methods for screening for a therapeutic agent, for suppressing the polynucleotide sequence, for treating a non-steroidal cancer, for screening for binding of an agent specifically to a polynucleotide, and for determining whether a patient is at risk for developing or having a non-steroidal cancer, pharmaceutical composition, uses of a therapeutic agent, an antisense molecule or a cell that expresses and / or contains the antisense molecule, at least one of the immunogenic membrane proteins, fragments, derivatives or homologues thereof or from a cell containing and / or expressing at least one of the immunogenic membrane proteins or fragments, derivatives or homologues thereof and an agent or antibody, agent, and kit for identifying a patient at risk of developing or have non-steroidal cancer [P] . BRPI0414446A . 2006-11-14

机译：筛选治疗剂，抑制多核苷酸序列，治疗非甾体类癌症，筛选试剂特异性结合多核苷酸的方法以及确定患者是否处于发展或患有非糖尿病风险的方法类固醇癌，药物组合物，表达和/或含有反义分子的治疗剂，反义分子或细胞，免疫原性膜蛋白，其片段，衍生物或同源物中至少一种或来自含有和/或含有细胞的细胞的用途或表达至少一种免疫原性膜蛋白或其片段，衍生物或同系物以及一种试剂或抗体，试剂和试剂盒，用于鉴定有发生或患有非甾体癌风险的患者
5. Nucleic acid, nucleic acid sequence, processes using a nucleic acid, using the vector, producing the polipeptu00ecdeo, administering the polipeptu00ecdeo,To treat a disease or disorder in an animal I, to determine if a disease or disorder in an animal I, to produce any polipeptu00ecdeo,Process for identifying, isolating and amplifying a nucleic acid sequence of neublastina,To diagnose or assess for the presence of a disease or disorder or a predisposiu00e7u00e3opara desnvolvu00ea them,To evaluate a polipeptu00ecdeo of neublastina purified or a derivative or fragment of a modulator activity of precedents for activity in treating or preventing a disease.To treat a neurological distu00fabio, using a sequence of one or more nucleic acids, and for identifying a candidate compound that induces a biological effect mediated by neuroblastina, vector,The cell transformed with nucleic acid, polipeptu00ecdeo, cmposiu00e7u00e3o, antibody, synthetic gene, and set. [P] . BR9911908A . 2001-03-27

机译：核酸，核酸序列，使用核酸的过程，使用载体的过程，产生聚肽，施用聚肽以治疗动物I中的疾病或失调，以确定动物中的疾病或失调I，生产任何脂肽，鉴定，分离和扩增神经母细胞核素核酸序列的方法，诊断或评估疾病或病症或它们的易感性，评估纯化的神经母细胞的脂肽或先例的调节剂活性的衍生物或片段，用于治疗或预防疾病。使用一种或多种核酸序列治疗神经系统疾病，并鉴定候选化合物诱导由神经母细胞，载体介导的生物学效应的细胞，该细胞用核酸，lipeptept，cmposi，抗体，合成基因和集合转化。